So the company is called BARD1 but the actual BARD1 tests are now almost only a footnote. Also the planned timeline for the much hyped BARD1 ovarian/breast/lung (lol does anyone even remember lung?) tests are now just TBA. Three years later and no tangible progress on that front it seems. Given that, I think I can be forgiven for being skeptical about their ~18 month(!) to market for SubB2M.
This has been my first foray into biotech stocks and it's been a real eye opener. I still hold a small parcel but it's a bit sad really. No wonder Dr IFF is taking them to court.
Ann: BARD1 Investor Presentation, page-3
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
45.0¢ |
Change
0.010(2.27%) |
Mkt cap ! $50.18M | |||
| Open | High | Low | Value | Volume |
| 45.0¢ | 45.0¢ | 43.5¢ | $15.99K | 35.87K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 507 | 43.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 45.0¢ | 1925 | 1 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |